Literature DB >> 11084302

Spontaneous regression of merkel cell carcinoma: a comparative study of TUNEL index and tumor-infiltrating lymphocytes between spontaneous regression and non-regression group.

T Inoue1, K Yoneda, M Manabe, T Demitsu.   

Abstract

Some Merkel cell carcinomas (MCC) have been reported to regress spontaneously. To clarify the mechanisms of spontaneous regression (SR) of MCC, we analyzed the TUNEL index, the labeling index of proliferating cell nuclear antigen (PCNA), the labeling index of bcl-2 protein, and the expression of p53 of the tumor cells. We also evaluated the number of infiltrating lymphocytes surrounding the tumor in the tissue specimens. Among seven patients with MCC (SR: n=4; non-regression (NR): n=3), the TUNEL index in the SR group was significantly higher than that in NR group (5.2 and 2.0%, respectively). In addition, the number of lymphocytes around the tumor nests was also significantly increased in the SR group compared to NR group (1576 and 663 cells/mm(2), respectively). Most of the infiltrating lymphocytes were UCHL-1 positive T-cells. There were no significant differences of the PCNA labeling index, the bcl-2 protein labeling index, and the expression p53 between SR and NR group. These results indicate that apoptosis and local T-cell mediated immune response might be involved in spontaneous regression of MCC.

Entities:  

Mesh:

Year:  2000        PMID: 11084302     DOI: 10.1016/s0923-1811(00)00103-1

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  12 in total

Review 1.  Immune surveillance of tumors.

Authors:  Jeremy B Swann; Mark J Smyth
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

2.  Characterization of three newly established rat sarcoma cell clones.

Authors:  Monika Holubova; Martin Leba; Markéta Sedmikova; Luca Vannucci; Vratislav Horak
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-11-13       Impact factor: 2.416

Review 3.  The anticancer immune response: indispensable for therapeutic success?

Authors:  Laurence Zitvogel; Lionel Apetoh; François Ghiringhelli; Fabrice André; Antoine Tesniere; Guido Kroemer
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

4.  Merkel cell carcinoma with lymphoepithelioma-like pattern: a case report of an exceedingly rare variant of merkel cell carcinoma with lymph node metastases at presentation.

Authors:  Soumaya Ben Abdelkrim; Abdelmajid Dhouibi; Adnène Moussa; Rim Hadhri; Leila Njim; Khalifa Mighri; Abdelfatteh Zakhama
Journal:  Case Rep Pathol       Date:  2011-09-06

Review 5.  Merkel cell carcinoma of the head and neck: pathogenesis, current and emerging treatment options.

Authors:  Alok T Saini; Brett A Miles
Journal:  Onco Targets Ther       Date:  2015-08-19       Impact factor: 4.147

6.  Merkel cell carcinoma of the head and neck: a single institutional experience.

Authors:  G Morand; D Vital; T Pézier; D Holzmann; M Roessle; A Cozzio; G F Huber
Journal:  J Skin Cancer       Date:  2013-01-10

7.  Merkel cell carcinoma.

Authors:  Virve Koljonen
Journal:  World J Surg Oncol       Date:  2006-02-08       Impact factor: 2.754

8.  The role of the immune response in merkel cell carcinoma.

Authors:  Pierre L Triozzi; Anthony P Fernandez
Journal:  Cancers (Basel)       Date:  2013-02-28       Impact factor: 6.639

9.  Inflammatory cell distribution in primary merkel cell carcinoma.

Authors:  Rachel Wheat; Claudia Roberts; Tim Waterboer; Jane Steele; Jerry Marsden; Neil M Steven; David J Blackbourn
Journal:  Cancers (Basel)       Date:  2014-05-06       Impact factor: 6.639

10.  Merkel cell carcinoma in immunosuppressed patients.

Authors:  Janice E Ma; Jerry D Brewer
Journal:  Cancers (Basel)       Date:  2014-06-27       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.